Ratio between Right Ventricular Longitudinal Strain and Pulmonary Arterial Systolic Pressure: Novel Prognostic Parameter in Patients Undergoing Cardiac Resynchronization Therapy.
Silvia DeaconuAlexandru DeaconuAlina Ioana ScărlătescuIoana PetreSebastian OnciulAura VijiiacDiana ZamfirGabriela MarascuCorneliu IorgulescuAndrei Dan RaduStefan BogdanRadu VatasescuPublished in: Journal of clinical medicine (2021)
A total of 54 patients (64.0 ± 13.8 years; 58% male) were included. After 33 ± 12.9 months, the primary endpoint occurred in 18 patients. Baseline RVGLS/PASP and RVfwS/PASP showed good discriminative ability for response to CRT (AUC = 0.88, 95% CI (0.74-1) and AUC = 0.87, 95% CI (0.77-1)). RVGLS/PASP and RVfwS/PASP were significantly associated with high risk of events at univariate analysis (HR 0.039, 95% CI (0.001-0.8) p < 0.05, respectively HR = 0.049, 95% CI (0.0033-0.72), p < 0.05). Upon multivariate Cox regression analysis, RVGLS/PASP and RVfwS/PASP remained associated with high risk of events (HR 0.018, 95% CI (0.0005-0.64), p = 0.02 and HR 0.015, 95% CI (0.0004-0.524), p = 0.01) after correction for gender, etiology, QRS duration and morphology. Conclusions: Indexing RV longitudinal strain (global and free wall) by PASP provides a parameter, which independently identifies patients with high risk of cardiovascular events and predicts non-response to CRT.
Keyphrases
- cardiac resynchronization therapy
- end stage renal disease
- cardiovascular events
- left ventricular
- patients undergoing
- heart failure
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- coronary artery disease
- peritoneal dialysis
- mycobacterium tuberculosis
- type diabetes
- pulmonary hypertension
- gene expression
- patient reported outcomes
- genome wide